AzTrials
AzTrials

EpilepsyNCT07827248

The Effect of a Kolcaba's Comfort Theory-Based Educational Intervention on the Quality of Life of Patients With Epilepsy

A study testing Kolcaba Comfort Theory-Based Educational Program in people with Epilepsy, run by Ataturk University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study is a two-arm controlled interventional study designed to evaluate the effect of a Kolcaba's Comfort Theory-based educational intervention on the quality of life of patients with epilepsy. Eligible participants will be assigned to either an intervention group or a control group. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Epilepsy
What is being tested?
Kolcaba Comfort Theory-Based Educational Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Sep 2026to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Being 18 years of age or older
  • Having a diagnosis of epilepsy for at least 6 months
  • Being able to read and write in Turkish
  • Having access to a reachable telephone for communication
  • Clinical diagnosis and hospital records will be used to confirm eligibility criteria, along with participant self-report

Who cannot join

  • Presence of psychiatric disorders affecting cognitive processes (e.g., dementia, schizophrenia)
  • Having chronic diseases other than epilepsy
  • Being pregnant
  • Willingness to withdraw from the study at any stage

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Ağrı Eğitim ve Araştırma Hastanesi

    Ağrı, Ağrı, 04100

Other trials in Turkey (Türkiye)

About this study

This study is a two-arm controlled interventional study designed to evaluate the effect of a Kolcaba's Comfort Theory-based educational intervention on the quality of life of patients with epilepsy. Eligible participants will be assigned to either an intervention group or a control group. Participants in the intervention group will receive a structured educational program developed according to the principles of Kolcaba's Comfort Theory in addition to routine care, whereas participants in the control group will receive routine care only. Quality of life assessments will be conducted at baseline and after the intervention period using validated measurement instruments. The primary objective is to determine whether the theory-based educational intervention improves the quality of life of patients with epilepsy compared with routine care.

Conditions
Epilepsy
Being tested
Kolcaba Comfort Theory-Based Educational Program
Medical subject headings
Epilepsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Kolcaba Comfort Theory-Based Educational ProgramBehavioural

    Also called Kolcaba Comfort Theory-Based Educational Intervention, Epilepsy Education Program Based on Kolcaba Theory

    This intervention consists of a structured educational program based on Kolcaba's Comfort Theory. The program is designed to improve comfort and quality of life in patients with epilepsy. It includes planned educational sessions addressing physical, psychospiritual, sociocultural, and environmental comfort needs. The education is delivered by the researcher in addition to routine clinical care.

Study groups in NCT07827248
Study groupRoleWhat they receive
Intervention GroupExperimentalParticipants in the intervention group will receive a structured educational program based on Kolcaba's Comfort Theory in addition to routine clinical care. The education will be delivered through planned sessions focusing on improving comfort, self-management, and quality of life in patients with epilepsy. The content includes physical, psychospiritual, sociocultural, and environmental comfort dimensions.
Receives: Behavioral: Kolcaba Comfort Theory-Based Educational Program
Control GroupNo interventionParticipants in the control group will receive routine clinical care only. No structured educational intervention will be provided during the study period. Outcomes will be assessed at baseline and after the study period using the same measurement tools as the intervention group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of Life in Patients with Epilepsy (QOLIE-31)

    The primary outcome is the quality of life of patients with epilepsy. Quality of life will be assessed using a validated epilepsy-specific quality of life scale before and after the Kolcaba Comfort Theory-based educational intervention. Changes in quality of life scores between baseline and post-intervention measurements will be analyzed.

    Measured: Baseline and post-intervention (8-12 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2026
  2. Study start30 Sep 2026 (estimated)
  3. Primary completionNov 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07827248
Sponsor's protocol ID
B.30.2.ATA.0.01.00/952
Other IDs
TDK-2026-17230
Status last verified
Sep 2026
First submitted
14 Sep 2026
Last updated
18 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Kolcaba Comfort Theory-Based Educational Program in people with Epilepsy, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Neşe AYKUT (+90 536 052 37 58, naykut@agri.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of Life in Patients with Epilepsy (QOLIE-31) (time frame: Baseline and post-intervention (8-12 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in